ACTA1 and cancer: The expression of CCL5 was mostly detected in inflammatory cells and in some cancer cells (Figure 4A-4B), but only sparse CAFs were CCL5 positive, as assessed by immunohistochemical co-localization of CCL5 and CAF marker αSMA (data not shown).